Market Overview:
The global coronavirus treatment drugs market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of coronavirus infections, rising demand for novel and effective therapies, and growing investments by pharmaceutical companies in R&D for the development of new drugs. The global coronavirus treatment drugs market is segmented on the basis of type into corticosteroids, anti-viral agents, monoclonal antibodies (mAbs), kinase inhibitors, and others. The corticosteroids segment is expected to account for the largest share of the global market in 2018. This can be attributed to their wide use as therapy for various respiratory diseases including bronchitis, pneumonia, and asthma. The anti-viral agents segment is projected to grow at a highest CAGR during the forecast period owing to increasing awareness about these drugs among patients and healthcare professionals.
Product Definition:
The coronavirus is a virus that primarily affects the respiratory system. It can cause severe respiratory illness, including pneumonia, and can be fatal. There is no specific cure for coronavirus infection and there is no vaccine available to prevent its spread. Treatment focuses on relieving symptoms and supporting the patient's overall health. Treatment options include antibiotics to treat any secondary bacterial infections, oxygen therapy, cough suppressants, and fluids to prevent dehydration.
Corticosteroids:
Corticosteroids are the group of drugs, which acts on Cortisoleceptors present in the brain and nervous system. It reduces inflammation by inhibiting cytokines production. Corticosteroid treatment is used for inflammatory diseases like asthma, psoriasis etc., In case of viral infection like COVID-19 it’s used to reduce immune response to virus so that patient can recover faster.
Anti-viral:
Anti-viral is a drug or medication used to prevent or reduce the spread of viral infections. Anti-viral drugs are mainly used for two purposes, namely to treat acute (sudden and short term) as well as chronic (long term) viral infections.
Application Insights:
Based on the application, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacy segment dominated the global coronavirus treatment drugs market in 2017 owing to factors such as presence of a large patient base with chronic diseases and high healthcare spending. In addition, increasing number of hospitals due to increase in population is expected to contribute towards revenue growth over the forecast period.
The retail pharmacy segment is anticipated to witness lucrative growth during the study period owing to growing awareness among people regarding availability of medicines at affordable prices and convenience. Moreover, an increase in demand for specialty pharmaceutical products that are effective against viral infections will boost industry expansion over next few years.
Regional Analysis:
North America dominated the global market in 2017. The coronavirus outbreak has resulted in a surge in demand for treatment drugs, which can be attributed to their increasing use as therapeutic alternatives for anti-viral medication and corticosteroids. Moreover, the presence of key players such as Gilead Sciences, Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson Services, Inc.; and Merck & Co., Inc., has contributed to market growth over this region.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as growing healthcare expenditure by governments along with rising awareness about these treatments among patients and physicians especially after approval of mAb therapies for treatment of novel viruses like COVID-19 by regulatory agencies like FDA (U.S.) and EMEA (Europe). Availability of generic versions at low prices also contributes toward regional growth prospects over the forecast period (2018 - 2030).
Growth Factors:
- Increasing incidence of coronavirus infections: The increasing incidence of coronavirus infections is one of the key growth drivers for the global coronavirus treatment drugs market. According to a study by the World Health Organization (WHO), over 71,000 cases of novel coronavirus infection were reported from January 2019 to June 2019. This number is expected to rise in the coming years, owing to the increasing prevalence of this virus across the globe.
- Growing demand for effective and safe antiviral drugs: The growing demand for effective and safe antiviral drugs is another major factor driving growth in the global coronavirus treatment drugs market. With no specific cure or vaccine available till date for treating COVID-19, patients are increasingly relying on antiviral medications for relief from symptoms and improving their chances of recovery. This is expected to result in robust demand for such drugs in future years as well.
- Rising R&D investments by pharmaceutical companies: Pharmaceutical companies are investing heavily in research and development (R&D) activities aimed at developing novel therapies against various types of viruses, including COVID-19 virus strains. This is likely to result in increased availability of new and innovative treatments options over time, fueling growth prospects for the global coronavirus treatment drugs market during forecast period 2020-2025 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Coronavirus Treatment Drugs Market Research Report
By Type
Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc, CanSino Biologics, Sinovac Biotech, Novavax, Inc, Glenmark Pharmaceuticals Limited, Dr. Reddy's Laboratories, Merck & Co., Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Coronavirus Treatment Drugs Market Report Segments:
The global Coronavirus Treatment Drugs market is segmented on the basis of:
Types
Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Serum Institute of India
- Pfizer Inc
- AstraZeneca Plc
- Bharat Biotech International Limited
- Cadila Healthcare Limited
- Johnson & Johnson
- Moderna
- GlaxoSmithKline Plc
- CanSino Biologics
- Sinovac Biotech
- Novavax, Inc
- Glenmark Pharmaceuticals Limited
- Dr. Reddy's Laboratories
- Merck & Co., Inc
Highlights of The Coronavirus Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Anti-viral
- Monoclonal Antibodies
- Kinase Inhibitors
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coronavirus Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for coronavirus, but antiviral drugs can help to reduce the severity of symptoms. Treatment typically includes a combination of two or more drugs. Some common treatments include amantadine and rimantadine (Symmetrel), oseltamivir (Tamiflu), zanamivir (Relenza) and peramivir (Rapidol).
Some of the key players operating in the coronavirus treatment drugs market are Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc, CanSino Biologics, Sinovac Biotech, Novavax, Inc, Glenmark Pharmaceuticals Limited, Dr. Reddy's Laboratories, Merck & Co., Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Coronavirus Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Coronavirus Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Coronavirus Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Coronavirus Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Coronavirus Treatment Drugs Market Size & Forecast, 2018-2028
4.5.1 Coronavirus Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Coronavirus Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Coronavirus Treatment Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Coronavirus Treatment Drugs Market Size Forecast by Type
5.2.1 Corticosteroids
5.2.2 Anti-viral
5.2.3 Monoclonal Antibodies
5.2.4 Kinase Inhibitors
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Coronavirus Treatment Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Coronavirus Treatment Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Coronavirus Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Coronavirus Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Coronavirus Treatment Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Coronavirus Treatment Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Coronavirus Treatment Drugs Market Size Forecast by Type
9.6.1 Corticosteroids
9.6.2 Anti-viral
9.6.3 Monoclonal Antibodies
9.6.4 Kinase Inhibitors
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Coronavirus Treatment Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Coronavirus Treatment Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Coronavirus Treatment Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Coronavirus Treatment Drugs Market Size Forecast by Type
10.6.1 Corticosteroids
10.6.2 Anti-viral
10.6.3 Monoclonal Antibodies
10.6.4 Kinase Inhibitors
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Coronavirus Treatment Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Coronavirus Treatment Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Coronavirus Treatment Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Coronavirus Treatment Drugs Market Size Forecast by Type
11.6.1 Corticosteroids
11.6.2 Anti-viral
11.6.3 Monoclonal Antibodies
11.6.4 Kinase Inhibitors
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Coronavirus Treatment Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Coronavirus Treatment Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Coronavirus Treatment Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Coronavirus Treatment Drugs Market Size Forecast by Type
12.6.1 Corticosteroids
12.6.2 Anti-viral
12.6.3 Monoclonal Antibodies
12.6.4 Kinase Inhibitors
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Coronavirus Treatment Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Coronavirus Treatment Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Coronavirus Treatment Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Coronavirus Treatment Drugs Market Size Forecast by Type
13.6.1 Corticosteroids
13.6.2 Anti-viral
13.6.3 Monoclonal Antibodies
13.6.4 Kinase Inhibitors
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Coronavirus Treatment Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Coronavirus Treatment Drugs Market: Competitive Dashboard
14.2 Global Coronavirus Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Serum Institute of India
14.3.2 Pfizer Inc
14.3.3 AstraZeneca Plc
14.3.4 Bharat Biotech International Limited
14.3.5 Cadila Healthcare Limited
14.3.6 Johnson & Johnson
14.3.7 Moderna
14.3.8 GlaxoSmithKline Plc
14.3.9 CanSino Biologics
14.3.10 Sinovac Biotech
14.3.11 Novavax, Inc
14.3.12 Glenmark Pharmaceuticals Limited
14.3.13 Dr. Reddy's Laboratories
14.3.14 Merck & Co., Inc
